Previous
Pause
Siguiente
Skip to Navigation
↓
Congresos
Año
Año
Año
-Año
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Investigador
Todos
usuario_prueba
Almeida e Silva, Filomena Augusta
Angás Pajas, Jorge
Arenal , Raúl
Baptista , Pedro Miguel
Bernechea Navarro, María
Bover Arbós, Pere
Calvo Lacosta, Jorge Hugo
Carstensen , Hans-Heinrich
Cazcarro Castellano, Ignacio
Cobarrubias Baglietto, Sebastián Felipe
Espina Cadena, Laura
Fernandez Antoran, David
Gil Hernández, Vanesa
Gracia Lostao, Ana Isabel
Gurauskis , Jonas
Gómez Candón, David
Hernández Ainsa, Silvia
Hernández Latas, José Antonio
Hurtado Guerrero, Ramón
Jiménez Schuhmacher, Alberto
Juarez-Perez , Emilio J.
Köhler , Ralf
Millán Gasca, Javier
Montiel , Manuel
Muñoz Soro, José Félix
Olmo , Jose
Ordovás Vidal, Laura
Philippidis , George
Ramón García, Santiago
Roque , Carla
Schoorlemmer , Jon
Sola , Daniel
Stavridis , Stelios
Sánchez Martínez, Diego
Velasco Lozano, Susana
Íñiguez Dieste, David
Título
Título
Año
Sanfetrinem, repurposing an oral beta-lactam with intracellular activity for the treatment of tuberculosis
2019
Nuevos métodos para la búsqueda de combinaciones sinérgicas
2019
Towards the elucidation of the rifampicin/beta-lactam synergy in mycobacteria
2019
New methodologies to test antibiotic susceptibility against emerging pathogens in cystic fibrosis
2019
Mathematical model of meropenem against Mycobacterium tuberculosis
2019
ESTUDIOS DE ELUCIDACIÓN DEL MODO DE ACCIÓN DE LAS AVERMECTINAS FRENTE A MYCOBACTERIUM
2019
Mode of action elucidation studies of the avermectins against Mycobacteria
2019
DEVELOPMENT OF A HIGH-THROUGHPUT METHOD FOR SYNERGISTIC DRUG COMBINATIONS SCREENING
2019
Beta-lactams for Tuberculosis Treatment
2019
Mode of action elucidation studies of a new chemical series active against Mycobacteria and other microbial pathogens
2019
TOWARDS THE ELUCIDATION OF THE MODE OF ACTION OF A NEW CHEMICAL SERIES WITH ANTIMICROBIAL ACTIVITY
2019
Triple oral beta-lactam containing therapy for Buruli ulcer treatment shortening
2019
A novel methodology to identify synergistic drug combinations against non-tuberculous mycobacteria in cystic fibrosis
2019
Towards efficient in vitro screening tools to discover new clinical options in the treatment of non-tuberculous Mycobacteria
2019
PRELIMINARY STUDIES FOR THE ELUCIDATION OF THE MODE OF ACTION OF THE AVERMECTINS AS ANTI-TB AGENTS
2019
Towards the elucidation of the rifampicin/beta-lactam synergy in mycobacteria
2019
In vitro profiling of anthelmintic avermectins against non-tuberculous mycobacteria
2019
Estudios iniciales para la caracterización del modo de acción molecular de las avermectinas como agentes anti-tuberculosos
2018
Towards the elucidation of rifampicin/betalactam synergistic interactions against M. tuberculosis
2018
Discovery and Development of Antimicrobials and Mechanisms of Drug Resistance
2018
Páginas
« primera
‹ anterior
1
2
3
4
siguiente ›
última »